Grb2 Is Regulated by Foxd3 and Has Roles in Preventing Accumulation and Aggregation of Mutant Huntingtin

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Baksi, Shounak ^a   Jana, Nihar R ^b   Bhattacharyya, Nitai Pada ^a   Mukhopadhyay, Debashis ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

^b NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HUNTINGTIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXD3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUNTINGTON CHOREA; LYSOSOME; MALE; MOUSE; NERVE CELL; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION;

ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRB2 ADAPTOR PROTEIN; HUNTINGTON DISEASE; LYSOSOMES; MALE; MICE; MICE, INBRED CBA; MICROSCOPY, CONFOCAL; MUTANT PROTEINS; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHAGOSOMES; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84885152729     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076792     Document Type: Article

References (34)

1. Harper PS, (1996) New genes for old diseases: the molecular basis of myotonic dystrophy and Huntington's disease. The Lumleian Lecture 1995 J R Coll Physicians Lond 30: 221-231.
2. Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, et al. (2007) Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet 16: 2600-2615. doi:10.1093/hmg/ddm217. PubMed: 17704510.
3. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, et al. (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9: 2799-2809. doi:10.1093/hmg/9.19.2799. PubMed: 11092756.
4. Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, et al. (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9: 503-513. doi:10.1093/hmg/9.4.503. PubMed: 10699173.
5. Liu YF, Deth RC, Devys D, (1997) SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes. J Biol Chem 272: 8121-8124. doi:10.1074/jbc.272.13.8121. PubMed: 9079622.
6. Tari AM, Lopez-Berestein G, (2001) GRB2: a pivotal protein in signal transduction. Semin Oncol 28: 142-147. doi:10.1053/sonc.2001.28555. PubMed: 11706405.
7. Martinu L, Santiago-Walker A, Qi H, Chou MM, (2002) Endocytosis of epidermal growth factor receptor regulated by Grb2-mediated recruitment of the Rab5 GTPase-activating protein RN-tre. J Biol Chem 277: 50996-51002. doi:10.1074/jbc.M204869200. PubMed: 12399475.
8. Huang F, Sorkin A, (2005) Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Mol Biol Cell 16: 1268-1281. doi:10.1091/mbc.E04-09-0832. PubMed: 15635092.
9. Sofroniew MV, Howe CL, Mobley WC, (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24: 1217-1281. doi:10.1146/annurev.neuro.24.1.1217. PubMed: 11520933.
10. Harjes P, Wanker EE, (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 28: 425-433. doi:10.1016/S0968-0004(03)00168-3. PubMed: 12932731.
11. Weigel D, Jäckle H, (1990) The fork head domain: a novel DNA binding motif of eukaryotic transcription factors? Cell 63: 455-456. doi:10.1016/0092-8674(90)90439-L. PubMed: 2225060.
12. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, et al. (2006) Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15: 965-977. doi:10.1093/hmg/ddl013. PubMed: 16467349.
13. Lee JM, Ivanova EV, Seong IS, Cashorali T, Kohane I, et al. (2007) Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism. PLOS Genet 3: e135. doi:10.1371/journal.pgen.0030135. PubMed: 17708681.
14. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493-506. doi:10.1016/S0092-8674(00)81369-0. PubMed: 8898202.
15. Maheshwari M, Samanta A, Godavarthi SK, Mukherjee R, Jana NR, (2012) Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease. J Biol Chem 287: 29949-29957. doi:10.1074/jbc.M112.371724. PubMed: 22787151.
16. Gines S, Ivanova E, Seong IS, Saura CA, MacDonald ME, (2003) Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells. J Biol Chem 278: 50514-50522. doi:10.1074/jbc.M309348200. PubMed: 14522959.
17. Gines S, Seong IS, Fossale E, Ivanova E, Trettel F, et al. (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum Mol Genet 12: 497-508. doi:10.1093/hmg/ddg046. PubMed: 12588797.
18. Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, et al. (2008) Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci 28: 10720-10733. doi:10.1523/JNEUROSCI.2126-08.2008. PubMed: 18923047.
19. Xifró X, García-Martínez JM, Del Toro D, Alberch J, Pérez-Navarro E, (2008) Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells. J Neurochem 105: 1596-1612. doi:10.1111/j.1471-4159.2008.05252.x. PubMed: 18221365.
20. Quintanilla RA, Jin YN, Fuenzalida K, Bronfman M, Johnson GV, (2008) Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease. J Biol Chem 283: 25628-25637. doi:10.1074/jbc.M804291200. PubMed: 18640979.
21. Subramaniam S, Sixt KM, Barrow R, Snyder SH, (2009) Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324: 1327-1330. doi:10.1126/science.1172871. PubMed: 19498170.
22. Raychaudhuri M, Mukhopadhyay D, (2010) Grb2-mediated alteration in the trafficking of AbetaPP: insights from Grb2-AICD interaction. J Alzheimers Dis 20: 275-292. PubMed: 20164575.
23. Choudhury KR, Raychaudhuri S, Bhattacharyya NP, (2012) Identification of HYPK-Interacting Proteins Reveals Involvement of HYPK in Regulating Cell Growth, Cell Cycle, Unfolded Protein Response and Cell Death. PLOS ONE 7: e51415. doi:10.1371/journal.pone.0051415. PubMed: 23272104.
24. Majumder P, Raychaudhuri S, Chattopadhyay B, Bhattacharyya NP, (2007) Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range. Cell Mol Neurobiol 27: 1127-1145. doi:10.1007/s10571-007-9220-7. PubMed: 17902043.
25. Ghose J, Sinha M, Das E, Jana NR, Bhattacharyya NP, (2011) Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease. PLOS ONE 6: e23837. doi:10.1371/journal.pone.0023837. PubMed: 21887328.
26. Sinha M, Ghose J, Das E, Bhattarcharyya NP, (2010) Altered microRNAs in STHdh(pp. Q111)/Hdh(Q111) cells: miR-146a targets TBP. Biochem Biophys Res Commun 396: 742-747.
27. Raychaudhuri S, Sinha M, Mukhopadhyay D, Bhattacharyya NP, (2008) HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity. Hum Mol Genet 17: 240-255. PubMed: 17947297.
28. Banerjee M, Datta M, Majumder P, Mukhopadhyay D, Bhattacharyya NP, (2010) Transcription regulation of caspase-1 by R393 of HIPPI and its molecular partner HIP-1. Nucleic Acids Res 38: 878-892. PubMed: 19934260.
29. Datta M, Bhattacharyya NP, (2011) Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI). J Biol Chem 286: 33759-33769. doi:10.1074/jbc.M111.265173. PubMed: 21832040.
30. Sinha M, Ghose J, Bhattarcharyya NP, (2011) Micro RNA-214,-150,-146a and-125b target Huntingtin gene. RNA Biol 8: 1005-1021. doi:10.4161/rna.8.6.16035. PubMed: 22048026.
31. Bhattacharyya M, Ray S, Bhattacharya S, Chakrabarti A, (2004) Chaperone activity and prodan binding at the self-associating domain of erythroid spectrin. J Biol Chem 279: 55080-55088. doi:10.1074/jbc.M406418200. PubMed: 15492010.
32. Heng MY, Detloff PJ, Paulson HL, Albin RL, (2010) Early alterations of autophagy in Huntington disease-like mice. Autophagy 6: 1206-1208. PubMed: 20935460.
33. Katiyar P, Aplin AE, (2011) FOXD3 regulates migration properties and Rnd3 expression in melanoma cells. Mol Cancer Res 9: 545-552. doi:10.1158/1541-7786.MCR-10-0454. PubMed: 21478267.
34. Jiang X, Huang F, Marusyk A, Sorkin A, (2003) Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol Biol Cell 14: 858-870. doi:10.1091/mbc.E02-08-0532. PubMed: 12631709.